[1] |
BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424. DOI: 10.3322/caac.21492.
|
[2] |
FERLAY J, COLOMBET M, SOERJOMATARAM I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer, 2019, 144(8): 1941-1953. DOI: 10.1002/ijc.31937.
|
[3] |
China Association of Chinese Medicine. Guidelines for diagnosis and treatment of cancer in traditional Chinese medicine[M]. Beijing: China Press of Traditional Chinese Medicine, 2008.
中华中医药学会. 肿瘤中医诊疗指南[M]. 北京: 中国中医药出版社, 2008.
|
[4] |
ZHAO WJ, ZHU GQ, WU YM, et al. Comparative effectiveness of radiofrequency ablation, surgical resection and transplantation for early hepatocellular carcinoma by cancer risk groups: Results of propensity score-weighted analysis[J]. Onco Targets Ther, 2019, 12: 10389-10400. DOI: 10.2147/OTT.S224809.
|
[5] |
LIN HS. Traditional Chinese medicine diagnosis and treatment guidelines for malignant tumors[M]. Beijing: People's Medical Publishing House, 2014.
林洪生. 恶性肿瘤中医诊疗指南[M]. 北京: 人民卫生出版社, 2014.
|
[6] |
Chinese Societies of Liver Cancer and Clinical Oncology, Chinese Anti-Cancer Association; Liver Cancer Study Group, Chinese Society of Hepatology, Chinese Medical Association. Experts consensus on local ablation therapy for liver cancer[J]. Tumor, 2011, 31: 385-388. DOI: 10.3781/j.issn.1000-7431.2011.05.001.
中国抗癌协会肝癌专业委员会, 中国抗癌协会临床肿瘤学协作专业委员会, 中华医学会肝病学分会肝癌学组. 肝癌局部消融治疗规范的专家共识[J]. 肿瘤, 2011, 31: 385-388. DOI: 10.3781/j.issn.1000-7431.2011.05.001.
|
[7] |
Interventional Group, Chinese Society of Radiology, Chinese Medical Association. Expert consensus on standard therapeutic procedures of percutaneous radiofrequency ablation for liver tumor[J]. Chin J Radiol, 2012, 46(7): 581-585. DOI: 10.3760/cma.j.issn.1005-1201.2012.07.001.
中华医学会放射学分会介入学组. 经皮肝脏肿瘤射频消融治疗操作规范专家共识[J]. 中华放射学杂志, 2012, 46(7): 581-585. DOI: 10.3760/cma.j.issn.1005-1201.2012.07.001.
|
[8] |
MERKLE EM, ZECH CJ, BARTOLOZZI C, et al. Consensus report from the 7th International Forum for Liver Magnetic Resonance Imaging[J]. Eur Radiol, 2016, 26(3): 674-682. DOI: 10.1007/s00330-015-3873-2.
|
[9] |
Panel on Technical Management Standards for Tumor Ablation Therapy, National Health and Family Planning Commission of the People's Republic of China. Technical management standards for tumor ablation therapy (2017 edition)[J/CD]. Electronic J Liver Tumor, 2017, 4(4): 6-7. DOI: 10.3969/j.issn.2095-7815.2017.04.004.
国家卫计委肿瘤消融治疗技术管理规范专家组. 肿瘤消融治疗技术管理规范(2017年版)[J/CD]. 肝癌电子杂志, 2017, 4(4): 6-7. DOI: 10.3969/j.issn.2095-7815.2017.04.004.
|
[10] |
BOELLAARD R, DELGADO-BOLTON R, OYEN WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: Version 2.0[J]. Eur J Nucl Med Mol Imaging, 2015, 42(2): 328-354. DOI: 10.1007/s00259-014-2961-x.
|
[11] |
CHALIAN H, TORE HG, HOROWITZ JM, et al. Radiologic assessment of response to therapy: Comparison of RECIST versions 1.1 and 1.0[J]. Radiographics, 2011, 31(7): 2093-2105. DOI: 10.1148/rg.317115050.
|
[12] |
Guidelines Working Committee of Chinese Society of Clinical Oncology. Chinese Society of Clinical Oncology (CSCO) Guidelines for the diagnosis and treatment of primary liver cancer (2020 edition)[M]. Beijing: People's Medical Publishing House, 2020.
中国临床肿瘤学会指南工作委员会. 中国临床肿瘤学会(CSCO)原发性肝癌诊疗指南2020[M]. 北京: 人民卫生出版社, 2020.
|
[13] |
Bureau of Medical Administration, National Health Commission of the People's Republic of China. Guidelines for diagnosis and treatment of primary liver cancer in China (2019 edition)[J]. J Clin Hepatol, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 临床肝胆病杂志, 2020, 36(2): 277-292. DOI: 10.3969/j.issn.1001-5256.2020.02.007.
|
[14] |
ZHENG XY. Guidelines for clinical research of Chinese medicine (new drug) (trial)[M]. Beijing: China Medical Science Press, 2002: 208-213.
郑筱萸. 中药新药临床研究指导原则(试行)[M]. 北京: 中国医药科技出版社, 2002: 208-213.
|
[15] |
SI T, NING XJ, FENG XB, et al. Study on traditional Chinese medicine syndrome of 312 cases of primary liver cancer patients before and after the interventional embolization chemotherapy[J]. J Tradit Chin Med, 2015, 56(19): 1678-1681. DOI: 10.13288/j.11-2166/r.2015.19.016.
斯韬, 宁雪坚, 冯献斌, 等. 312例原发性肝癌患者血管介入栓塞化疗前后中医证候研究[J]. 中医杂志, 2015, 56(19): 1678-1681. DOI: 10.13288/j.11-2166/r.2015.19.016.
|
[16] |
ZHAO HJ, DU J, DONG BW, et al. Primary study on clinical TCM syndrome characteristics after microwave thermal ablation for hepatocellular carcinoma[J]. J Fujian Coll Tradit Chin Med, 2008, 18(3): 1-3. DOI: 10.3969/j.issn.1004-5627.2008.03.001.
赵红佳, 杜建, 董宝玮, 等. 肝癌患者微波热消融治疗术后中医证候特点[J]. 福建中医学院学报, 2008, 18(3): 1-3. DOI: 10.3969/j.issn.1004-5627.2008.03.001.
|
[17] |
AYUSO C, RIMOLA J, VILANA R, et al. Diagnosis and staging of hepatocellular carcinoma (HCC): Current guidelines[J]. Eur J Radiol, 2018, 101: 72-81. DOI: 10.1016/j.ejrad.2018.01.025.
|
[18] |
ZHENG JS, LI N, YUAN CW. CT-guided ablation therapy of liver tumor[M]. Beijing: People's Medical Publishing House, 2011: 1- 8.
郑加生, 李宁, 袁春旺. CT引导肝肿瘤消融治疗学[M]. 北京: 人民卫生出版社, 2011: 1- 8.
|
[19] |
ZHENG JS, LI N, YUAN CW. Image-guided ablation therapy of tumor[M]. Beijing: People's Medical Publishing House, 2013: 14-16.
郑加生, 李宁, 袁春旺. 影像引导肿瘤消融治疗学[M]. 北京: 人民卫生出版社, 2013: 14-16.
|
[20] |
LONG J, ZHENG JS, SUN B, et al. Microwave ablation of hepatocellular carcinoma with portal vein tumor thrombosis after transarterial chemoembolization: A prospective study[J]. Hepatol Int, 2016, 10(1): 175-184. DOI: 10.1007/s12072-015-9673-6.
|
[21] |
YUAN C, YUAN Z, CUI X, et al. Efficacy of ultrasound-, computed tomography-, and magnetic resonance imaging-guided radiofrequency ablation for hepatocellular carcinoma[J]. J Cancer Res Ther, 2019, 15(4): 784-792. DOI: 10.4103/jcrt.JCRT_836_18.
|
[22] |
ZHENG JS, LONG J, SUN B, et al. Transcatheter arterial chemoembolization combined with radiofrequency ablation can improve survival of patients with hepatocellular carcinoma with portal vein tumour thrombosis: Extending the indication for ablation?[J]. Clin Radiol, 2014, 69(6): e253-e263. DOI: 10.1016/j.crad.2014.01.015.
|
[23] |
LI W, WANG Y, GAO W, et al. HCC with tumor thrombus entering the right atrium and inferior vena cava treated by percutaneous ablation[J]. BMC Surg, 2017, 17(1): 21. DOI: 10.1186/s12893-017-0217-y.
|
[24] |
YUAN Z, WANG Y, HU C, et al. Efficacy of percutaneous thermal ablation combined with transarterial embolization for recurrent hepatocellular carcinoma after hepatectomy and a prognostic nomogram to predict survival[J]. Technol Cancer Res Treat, 2018, 17: 1533033818801362. DOI: 10.1177/1533033818801362.
|
[25] |
Society of Interventional Physicians, Chinese Medical Doctor Association. Chinese clinical practice guidelines for transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma[J]. Natl Med J China, 2018, 98: 3811-3819. DOI: 10.3760/cma.j.issn.0376-2491.2018.47.002.
中国医师协会介入医师分会. 中国肝细胞癌经动脉化疗栓塞治疗(TACE)临床实践指南[J]. 中华医学杂志, 2018, 98: 3811-3819. DOI: 10.3760/cma.j.issn.0376-2491.2018.47.002.
|
[26] |
HAN D, XU YM, YU J, et al. Clinical effect of Dachaihu decoction combined with modified Liujunzi decoction in prevention and treatment of post-embolization syndrome in liver cancer[J]. Beijing J Tradit Chin Med, 2011, 30(11): 842-843. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201111017.htm
韩冬, 徐咏梅, 于洁, 等. 大柴胡汤合六君子汤加减防治肝癌栓塞后综合征的临床研究[J]. 北京中医药, 2011, 30(11): 842-843. https://www.cnki.com.cn/Article/CJFDTOTAL-BJZO201111017.htm
|
[27] |
YANG HN, FAN QS, LIU FQ, et al. Effects of the traditional Chinese medicine Tiaogan Lipi granules on postembolization syndrome induced by transcatheter arterial chemoembolization for hepatocellular carcinoma[J/CD]. Chin J Inter Rad(Electronic Edition), 2021, 9(1): 20-24. DOI: 10.3877/cma.j.issn.2095-5782.2021.01.003.
杨海宁, 樊庆胜, 刘福全, 等. 中医调肝理脾法防治肝癌栓塞术后综合征的临床观察[J/CD]. 中华介入放射学电子杂志, 2021, 9(1): 20-24. DOI: 10.3877/cma.j.issn.2095-5782.2021.01.003.
|
[28] |
HAN Y, HUANG Z, JIANG ZC, et al. Expert consensus on targeted therapy for liver cancer (draft)[J/CD]. Electronic J Liver Tumor, 2020, 7(2): 2-11. DOI: 10.3760/cma.j.cn112137-20210425-00991.
韩玥, 黄振, 姜志超, 等. 肝癌靶向治疗专家共识(草案)[J/CD]. 肝癌电子杂志, 2020, 7(2): 2-11. DOI: 10.3760/cma.j.cn112137-20210425-00991.
|